Stefan Guhlke

2.1k total citations
55 papers, 1.6k citations indexed

About

Stefan Guhlke is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Epidemiology. According to data from OpenAlex, Stefan Guhlke has authored 55 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Radiology, Nuclear Medicine and Imaging, 28 papers in Oncology and 21 papers in Epidemiology. Recurrent topics in Stefan Guhlke's work include Radiopharmaceutical Chemistry and Applications (33 papers), Neuroendocrine Tumor Research Advances (21 papers) and Lung Cancer Research Studies (16 papers). Stefan Guhlke is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (33 papers), Neuroendocrine Tumor Research Advances (21 papers) and Lung Cancer Research Studies (16 papers). Stefan Guhlke collaborates with scholars based in Germany, United States and Canada. Stefan Guhlke's co-authors include Samer Ezziddin, Hans‐Jürgen Biersack, Amir Sabet, Hojjat Ahmadzadehfar, Hans Bender, G. Stöcklin, Charlotte J. Yong‐Hing, F. F. Knapp, Winfried A. Willinek and Frank Grünwald and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and International Journal of Cancer.

In The Last Decade

Stefan Guhlke

54 papers receiving 1.5k citations

Peers

Stefan Guhlke

ONCOL

RNMI

EPIDE

NEURO

PRM

John J. Zaknun Austria

Wouter A.P. Breeman Netherlands

Mihaela Ginj Switzerland

Erik de Blois Netherlands

Irina Velikyan Sweden

Ulrike Garske‐Román Sweden

A. Srinivasan United States

Jörg Schmitt Switzerland

Jan‐Erik Westlin Sweden

H. Bihl Germany

John J. Zaknun Austria

Stefan Guhlke

491 ×0.6

ONCOL

564 ×0.7

RNMI

487 ×0.7

EPIDE

273 ×0.5

NEURO

211 ×0.6

PRM

Citations per year, relative to Stefan Guhlke Stefan Guhlke (= 1×) peers John J. Zaknun

Countries citing papers authored by Stefan Guhlke

Since Specialization

Citations

This map shows the geographic impact of Stefan Guhlke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Guhlke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Guhlke more than expected).

Fields of papers citing papers by Stefan Guhlke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Guhlke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Guhlke. The network helps show where Stefan Guhlke may publish in the future.

Co-authorship network of co-authors of Stefan Guhlke

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Guhlke. A scholar is included among the top collaborators of Stefan Guhlke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Guhlke. Stefan Guhlke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sabet, Amir, Charlotte J. Yong‐Hing, Torjan Haslerud, et al.. (2014). Kann die Peptid-Radiorezeptortherapie bei diffuser Knochenmetastasierung noch sicher angewendet werden?. Nuklearmedizin - NuclearMedicine. 53(2). 54–59. 11 indexed citations

Sabet, Amir, Charlotte J. Yong‐Hing, Torjan Haslerud, et al.. (2014). Can peptide receptor radionuclide therapy be safely applied in florid bone metastases?. Nuklearmedizin - NuclearMedicine. 53(2). 54–59. 21 indexed citations

Ezziddin, Samer, K. Reichmann, Charlotte J. Yong‐Hing, et al.. (2013). Frühe Prädiktion des Ansprechens auf PRRT. Nuklearmedizin - NuclearMedicine. 52(5). 170–177. 8 indexed citations

Sabet, Amir, Ulrich‐Frank Pape, Hojjat Ahmadzadehfar, et al.. (2013). Long-Term Hematotoxicity After Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-Octreotate. Journal of Nuclear Medicine. 54(11). 1857–1861. 124 indexed citations

Reichmann, K., Charlotte J. Yong‐Hing, M. Damm, et al.. (2013). Early prediction of tumour response to PRRT. Nuklearmedizin - NuclearMedicine. 52(5). 170–177. 13 indexed citations

Sabet, Amir, et al.. (2012). Detektion von Knochenmetastasen in Patienten mit gastroenteropankreatischen neuroendokrinen Tumoren – Vergleich von Knochenszintigraphie und 177Lu-Octreotate-Scan. Nuklearmedizin - NuclearMedicine. 51(3). 95–100. 4 indexed citations

Ezziddin, Samer, Charlotte J. Yong‐Hing, Amir Sabet, et al.. (2012). Does the Pretherapeutic Tumor SUV in 68Ga DOTATOC PET Predict the Absorbed Dose of 177Lu Octreotate?. Clinical Nuclear Medicine. 37(6). e141–e147. 60 indexed citations

Biersack, Hans‐Jürgen, H. Palmedo, F. F. Knapp, et al.. (2011). Palliation and Survival After Repeated ¹⁸⁸Re-HEDP Therapy of Hormone-Refractory Bone Metastases of Prostate Cancer: A Retrospective Analysis. Journal of Nuclear Medicine. 52(11). 1721–1726. 42 indexed citations

Ezziddin, Samer, Amir Sabet, Charlotte J. Yong‐Hing, et al.. (2011). Response and Long-Term Control of Bone Metastases After Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-Octreotate. Journal of Nuclear Medicine. 52(8). 1197–1203. 49 indexed citations

10.

Bucerius, Jan, Jörn Schmaljohann, Ingrid Böhm, et al.. (2008). Feasibility of 18F-fluoromethylcholine PET/CT for imaging of vessel wall alterations in humans—first results. European Journal of Nuclear Medicine and Molecular Imaging. 35(4). 815–820. 51 indexed citations

11.

Palmedo, H., Michaël Reinhardt, Alexius Joe, et al.. (2006). Myocardial uptake characteristics of three99mTc-labeled tracers for myocardial perfusion imaging one hour after rest injection. Annals of Nuclear Medicine. 20(10). 663–670. 5 indexed citations

12.

Gündisch, Daniela, et al.. (2005). A simple and fast method for the preparation of n.c.a. 2-[18F]F-A85380 for human use. Applied Radiation and Isotopes. 63(4). 433–435. 9 indexed citations

13.

Minnerop, Martina, et al.. (2004). Imaging of central nAChReceptors with 2-[18F]F-A85380: optimized synthesis and in vitro evaluation in Alzheimer's disease. Applied Radiation and Isotopes. 61(6). 1235–1240. 28 indexed citations

14.

Gries, W., et al.. (2004). Steam sterilization and automatic dispensing of [18F]fludeoxyglucose (FDG) for injection. Applied Radiation and Isotopes. 62(4). 577–586. 9 indexed citations

15.

Heuser, Claudia, Stefan Guhlke, Alexander Matthies, et al.. (2004). Anti‐CD30‐scFv‐Fc‐IL‐2 antibody‐cytokine fusion protein that induces resting NK cells to highly efficient cytolysis of Hodgkin's lymphoma derived tumour cells. International Journal of Cancer. 110(3). 386–394. 15 indexed citations

16.

Matthies, Alexander, et al.. (2004). Imaging of prostate cancer metastases with 18 F-fluoroacetate using PET/CT. European Journal of Nuclear Medicine and Molecular Imaging. 31(5). 797–797. 43 indexed citations

17.

Palmedo, H., Peter Albers, Ingo G.H. Schmidt‐Wolf, et al.. (2003). Repeated Bone-Targeted Therapy for Hormone-Refractory Prostate Carcinoma: Randomized Phase II Trial With the New, High-Energy Radiopharmaceutical Rhenium-188 Hydroxyethylidenediphosphonate. Journal of Clinical Oncology. 21(15). 2869–2875. 109 indexed citations

18.

Guhlke, Stefan, et al.. (2000). Dose escalation study with rhenium-188 hydroxyethylidene diphosphonate in prostate cancer patients with osseous metastases. European Journal of Nuclear Medicine and Molecular Imaging. 27(2). 123–130. 122 indexed citations

19.

Hosono, Makoto, Masako Hosono, Thomas Haberberger, et al.. (1996). Localization of Small‐cell Lung Cancer Xenografts with Iodine‐125‐, Indium‐111‐, and Rhenium‐188‐Somatostatin Analogs. Japanese Journal of Cancer Research. 87(9). 995–1000. 14 indexed citations

20.

Guhlke, Stefan, Hans‐Jürgen Wester, Christian Bruns, & G. Stöcklin. (1994). (2-[18F]fluoropropionyl-(d)phe1)-octreotide, a potential radiopharmaceutical for quantitative somatostatin receptor imaging with PET: Synthesis, radiolabeling, in vitro validation and biodistribution in mice. Nuclear Medicine and Biology. 21(6). 819–825. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact